It is also approved to treat noncirrhotic metabolic dysfunction-associated steatohepatitis (MASH) in adults with moderate to advanced liver fibrosis
Research indicates that patients who discontinue GLP-1 medications typically regain 50% of their lost weight within one year
Treat "Tirzepatide vs Qsymia: GLP-1 vs Phentermine/Topiramate" as a way to pressure-test a decision before money, medication, or provider access is involved
The complexity of GLP-1 medications extends beyond just knowing expirationunderstanding compounded versus brand name, cost differences, and quality considerations determines treatment success
The goal is to make room for honest conversations, because eating disorder recovery isn't measured solely by what someone eats
The full effects on body composition, recovery, and wellbeing become established